logo

[breadcrumb_custom]

G1 Therapeutics Inc (GTHX) Stock: Navigating a Year of Stock Volatility

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. G1 Therapeutics Inc’s current trading price is -42.30% away from its 52-week high, while its distance from the 52-week low is 167.13%. The stock’s price range over this period has fluctuated between $1.08 and $5.00. The company, operating within the financial sector, had a trading volume of approximately 1.66 million for the day, which was noticeably lower than the average daily share volume of 1.9 million over the last 3 months.

G1 Therapeutics Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $5.00 on 02/08/24 and the lowest value was $1.08 on 10/09/23.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

G1 Therapeutics Inc (GTHX) has experienced a quarterly rise of 75.91% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 149.56M and boasts a workforce of 170 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.50, with a change in price of +1.61. Similarly, G1 Therapeutics Inc recorded 1,406,182 in trading volume during the last 100 days, posting a change of +141.24%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for GTHX stands at 1.30. Similarly, the long-term debt-to-equity ratio is also 1.30.

GTHX Stock Stochastic Average

Today, G1 Therapeutics Inc’s raw stochastic average for the past 50 days stands at 24.75%, indicating a rise from the raw stochastic average of the last 20 days, which was 24.75%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 15.83% and 10.96% respectively.

GTHX Stock Price Performance Analysis

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The metric has seen a significant loss of -5.41% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 69.71%. Over the past 30 days, the price of GTHX has leaped by -36.45%. And in the last five days, it has surged by 33.56%.

On Key

Related Posts